Now Enrolling

Patients who are at high risk for sudden cardiac arrest.

Now Enrolling

Patients who are at high risk for sudden cardiac arrest.

The Jewel IDE Study

A Clinical Evaluation of the Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) in subjects at high risk for sudden cardiac arrest to demonstrate the safety and clinical effectiveness of the Jewel P-WCD.

Providers

Now recruiting for a national study at selected sites across the US, primarily in the southern, midwest, and northeast states.

Patients

The Jewel detects specific life-threatening heart rhythms and delivers an electrical shock to restore normal heart activity.

This product is not currently commercially available for sale in the U.S.